Global Animal Biotechnology Market 2024-2028

The animal biotechnology market is forecasted to grow by USD 3654.45 mn during 2023-2028, accelerating at a CAGR of 3.01% during the forecast period. The report on the animal biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing growth strategies of market players, the growing focus on animal cloning, and the use of transgenic animals to produce recombinant proteins.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	2.82%
CAGR	3.01%
Incremental Value	$3654.45mn

Technavio's animal biotechnology market is segmented as below:

By Product

Drugs
Vaccines
Diagnostic tests
Others

By Animal Type

Livestock/production
Companion

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing prevalence of animal diseases as one of the prime reasons driving the animal biotechnology market growth during the next few years. Also, emergence of alternatives to animal testing and advancements in R and D for animal biotechnology will lead to sizable demand in the market.

The report on the animal biotechnology market covers the following areas:

Animal biotechnology market sizing
Animal biotechnology market forecast
Animal biotechnology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading animal biotechnology market vendors that include Anicell BioTech, Bayer AG, Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., EW Group GmBH, Genus Plc, Heska Corp., Hester Biosciences Ltd., IDEXX Laboratories Inc., Ivaoes LLC, Merck and Co. Inc., Neogen Corp., Pfizer Inc., Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., Vimian Group AB, Virbac Group, Z Link Biotech Co. Ltd., and Zeus Biotech Pvt. Ltd.. Also, the animal biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR72295

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Animal Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global animal biotechnology market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global animal biotechnology market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Animal Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Animal Type Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Drugs - Market size and forecast 2023-2028
Exhibit 34: Chart on Drugs - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Drugs - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Drugs - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Drugs - Year-over-year growth 2023-2028 (%)
6.4 Vaccines - Market size and forecast 2023-2028
Exhibit 38: Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
6.5 Diagnostic tests - Market size and forecast 2023-2028
Exhibit 42: Chart on Diagnostic tests - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Diagnostic tests - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Diagnostic tests - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Diagnostic tests - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Exhibit 50: Market opportunity by Product ($ million)
Exhibit 51: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Animal Type

7.1 Market segments
Exhibit 52: Chart on Animal Type - Market share 2023-2028 (%)
Exhibit 53: Data Table on Animal Type - Market share 2023-2028 (%)
7.2 Comparison by Animal Type
Exhibit 54: Chart on Comparison by Animal Type
Exhibit 55: Data Table on Comparison by Animal Type
7.3 Livestock/production - Market size and forecast 2023-2028
Exhibit 56: Chart on Livestock/production - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Livestock/production - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Livestock/production - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Livestock/production - Year-over-year growth 2023-2028 (%)
7.4 Companion - Market size and forecast 2023-2028
Exhibit 60: Chart on Companion - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Companion - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Companion - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Companion - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Animal Type
Exhibit 64: Market opportunity by Animal Type ($ million)
Exhibit 65: Data Table on Market opportunity by Animal Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2023-2028 (%)
Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ million)
Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Bayer AG
Exhibit 115: Bayer AG - Overview
Exhibit 116: Bayer AG - Business segments
Exhibit 117: Bayer AG - Key news
Exhibit 118: Bayer AG - Key offerings
Exhibit 119: Bayer AG - Segment focus
12.4 Biogenesis Bago SA
Exhibit 120: Biogenesis Bago SA - Overview
Exhibit 121: Biogenesis Bago SA - Product / Service
Exhibit 122: Biogenesis Bago SA - Key offerings
12.5 Boehringer Ingelheim International GmbH
Exhibit 123: Boehringer Ingelheim International GmbH - Overview
Exhibit 124: Boehringer Ingelheim International GmbH - Business segments
Exhibit 125: Boehringer Ingelheim International GmbH - Key news
Exhibit 126: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 127: Boehringer Ingelheim International GmbH - Segment focus
12.6 EW Group GmBH
Exhibit 128: EW Group GmBH - Overview
Exhibit 129: EW Group GmBH - Product / Service
Exhibit 130: EW Group GmBH - Key offerings
12.7 Heska Corp.
Exhibit 131: Heska Corp. - Overview
Exhibit 132: Heska Corp. - Business segments
Exhibit 133: Heska Corp. - Key news
Exhibit 134: Heska Corp. - Key offerings
Exhibit 135: Heska Corp. - Segment focus
12.8 IDEXX Laboratories Inc.
Exhibit 136: IDEXX Laboratories Inc. - Overview
Exhibit 137: IDEXX Laboratories Inc. - Business segments
Exhibit 138: IDEXX Laboratories Inc. - Key news
Exhibit 139: IDEXX Laboratories Inc. - Key offerings
Exhibit 140: IDEXX Laboratories Inc. - Segment focus
12.9 Ivaoes LLC
Exhibit 141: Ivaoes LLC - Overview
Exhibit 142: Ivaoes LLC - Product / Service
Exhibit 143: Ivaoes LLC - Key offerings
12.10 Merck and Co. Inc.
Exhibit 144: Merck and Co. Inc. - Overview
Exhibit 145: Merck and Co. Inc. - Business segments
Exhibit 146: Merck and Co. Inc. - Key news
Exhibit 147: Merck and Co. Inc. - Key offerings
Exhibit 148: Merck and Co. Inc. - Segment focus
12.11 Pfizer Inc.
Exhibit 149: Pfizer Inc. - Overview
Exhibit 150: Pfizer Inc. - Product / Service
Exhibit 151: Pfizer Inc. - Key news
Exhibit 152: Pfizer Inc. - Key offerings
12.12 Randox Laboratories Ltd.
Exhibit 153: Randox Laboratories Ltd. - Overview
Exhibit 154: Randox Laboratories Ltd. - Product / Service
Exhibit 155: Randox Laboratories Ltd. - Key offerings
12.13 Santa Cruz Biotechnology Inc.
Exhibit 156: Santa Cruz Biotechnology Inc. - Overview
Exhibit 157: Santa Cruz Biotechnology Inc. - Product / Service
Exhibit 158: Santa Cruz Biotechnology Inc. - Key offerings
12.14 Vimian Group AB
Exhibit 159: Vimian Group AB - Overview
Exhibit 160: Vimian Group AB - Product / Service
Exhibit 161: Vimian Group AB - Key offerings
12.15 Virbac Group
Exhibit 162: Virbac Group - Overview
Exhibit 163: Virbac Group - Business segments
Exhibit 164: Virbac Group - Key news
Exhibit 165: Virbac Group - Key offerings
Exhibit 166: Virbac Group - Segment focus
12.16 Z Link Biotech Co. Ltd.
Exhibit 167: Z Link Biotech Co. Ltd. - Overview
Exhibit 168: Z Link Biotech Co. Ltd. - Product / Service
Exhibit 169: Z Link Biotech Co. Ltd. - Key offerings
12.17 Zeus Biotech Pvt. Ltd.
Exhibit 170: Zeus Biotech Pvt. Ltd. - Overview
Exhibit 171: Zeus Biotech Pvt. Ltd. - Product / Service
Exhibit 172: Zeus Biotech Pvt. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations